76 related articles for article (PubMed ID: 19924028)
21. Suspects in the tale of lupus-associated thrombocytopenia.
Ziakas PD; Routsias JG; Giannouli S; Tasidou A; Tzioufas AG; Voulgarelis M
Clin Exp Immunol; 2006 Jul; 145(1):71-80. PubMed ID: 16792676
[TBL] [Abstract][Full Text] [Related]
22. Fetal alloimmune thrombocytopenia.
Bussel JB; Zabusky MR; Berkowitz RL; McFarland JG
N Engl J Med; 1997 Jul; 337(1):22-6. PubMed ID: 9203427
[TBL] [Abstract][Full Text] [Related]
23. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia.
Grau GE; Morrow D; Izui S; Lambert PH
J Immunol; 1986 Jan; 136(2):686-91. PubMed ID: 3455704
[TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
[TBL] [Abstract][Full Text] [Related]
26. Difference in megakaryocyte expression of GATA-1, IL-6, and IL-8 associated with maintenance of platelet counts in patients with plasma cell neoplasm with dysmegakaryopoiesis.
Kim H; Lee MK; Kim HR
Exp Hematol; 2019 May; 73():13-17.e2. PubMed ID: 30825517
[TBL] [Abstract][Full Text] [Related]
27. [Thrombopoietic effect of recombinant human thrombopoietin gene transferred to mice mediated by electric pulse on normal and experimental thrombocytopenia mice].
Zang W; Wei X; Wang S; Wang D
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):128-31. PubMed ID: 11877062
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and treatment of severe and prolonged thrombocytopenia in neonates.
Sola MC
Clin Perinatol; 2004 Mar; 31(1):1-14. PubMed ID: 15183652
[TBL] [Abstract][Full Text] [Related]
29. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Frey BM; Rafii S; Teterson M; Eaton D; Crystal RG; Moore MA
J Immunol; 1998 Jan; 160(2):691-9. PubMed ID: 9551904
[TBL] [Abstract][Full Text] [Related]
30. Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia.
Zaninetti C; Rivera J; Vater L; Ohlenforst S; Leinøe E; Böckelmann D; Freson K; Thiele T; Makhloufi H; Rath M; Eberl W; Wolff M; Freyer C; Wesche J; Zieger B; Felbor U; Heidel FH; Greinacher A
J Thromb Haemost; 2024 Apr; 22(4):1179-1186. PubMed ID: 38103735
[TBL] [Abstract][Full Text] [Related]
31. A clinical and molecular study of a Bedouin family with dysmegakaryopoiesis, mild anemia, and neutropenia cured by bone marrow transplantation.
Tamary H; Yaniv I; Stein J; Dgany O; Shalev Z; Shechter T; Resnitzky P; Shaft D; Zoldan M; Kornreich L; Levy R; Cohen A; Moser RA; Kapelushnik J; Shalev H
Eur J Haematol; 2003 Sep; 71(3):196-203. PubMed ID: 12930321
[TBL] [Abstract][Full Text] [Related]
32. Loss of GATA1 and gain of FLI1 expression during thrombocyte maturation.
Jagadeeswaran P; Lin S; Weinstein B; Hutson A; Kim S
Blood Cells Mol Dis; 2010 Mar; 44(3):175-80. PubMed ID: 20110178
[TBL] [Abstract][Full Text] [Related]
33. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
Bastida JM; Malvestiti S; Boeckelmann D; Palma-Barqueros V; Wolter M; Lozano ML; Glonnegger H; Benito R; Zaninetti C; Sobotta F; Schilling FH; Morgan NV; Freson K; Rivera J; Zieger B
Cells; 2022 Oct; 11(20):. PubMed ID: 36291092
[TBL] [Abstract][Full Text] [Related]
34. The polymorphic landscape analysis of GATA1 exons uncovered the genetic variants associated with higher thrombocytopenia in dengue patients.
Al Rimon R; Sayem M; Alam S; Al Saba A; Sanyal M; Amin MR; Kabir A; Chakraborty S; Nabi AHMN
PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010537. PubMed ID: 35771876
[TBL] [Abstract][Full Text] [Related]
35. New germline GATA1 variant in females with anemia and thrombocytopenia.
Svidnicki MCCM; Filho MAF; Brandão MM; Dos Santos M; de Oliveira Dias R; Tavares RS; Assis-Mendonça GR; Traina F; Saad STO
Blood Cells Mol Dis; 2021 May; 88():102545. PubMed ID: 33611093
[TBL] [Abstract][Full Text] [Related]
36. Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation.
Kratz CP; Niemeyer CM; Karow A; Volz-Fleckenstein M; Schmitt-Gräff A; Strahm B
Leukemia; 2008 Feb; 22(2):432-4. PubMed ID: 17713552
[No Abstract] [Full Text] [Related]
37. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
Tubman VN; Levine JE; Campagna DR; Monahan-Earley R; Dvorak AM; Neufeld EJ; Fleming MD
Blood; 2007 Apr; 109(8):3297-9. PubMed ID: 17209061
[TBL] [Abstract][Full Text] [Related]
38. Novel
Jurk K; Adenaeuer A; Sollfrank S; Groß K; Häuser F; Czwalinna A; Erkel J; Fritsch N; Marandiuc D; Schaller M; Lackner KJ; Rossmann H; Bergmann F
Cells; 2022 Sep; 11(19):. PubMed ID: 36231035
[TBL] [Abstract][Full Text] [Related]
39. Novel GATA1 mutation in residue D218 leads to macrothrombocytopenia and clinical bleeding problems.
Hermans C; De Waele L; Van Geet C; Freson K
Platelets; 2014; 25(4):305-7. PubMed ID: 23971719
[No Abstract] [Full Text] [Related]
40. Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.
Dührsen U; Kratz CP; Flotho C; Lauenstein T; Bommer M; König E; Brittinger G; Heimpel H
Ann Hematol; 2011 Mar; 90(3):301-6. PubMed ID: 20922527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
